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A B S T R A C T
The purpose of this study was to determine the plasmid architecture and context of resistance genes in multi-
drug resistant (MDR) Escherichia coli strains isolated from urinary tract infections in dogs. Illumina and single-
molecule real-time (SMRT) sequencing were applied to assemble the complete genomes of E. coli strains asso-
ciated with clinical urinary tract infections, which were either phenotypically MDR or drug susceptible. This
revealed that multiple distinct families of plasmids were associated with building an MDR phenotype. Plasmid-
mediated AmpC (CMY-2) beta-lactamase resistance was associated with a clonal group of IncI1 plasmids that has
remained stable in isolates collected up to a decade apart. Other plasmids, in particular those with an IncF
replicon type, contained other resistance gene markers, so that the emergence of these MDR strains was driven
by the accumulation of multiple plasmids, up to 5 replicons in speciﬁc cases. This study indicates that vulnerable
patients, often with complex clinical histories provide a setting leading to the emergence of MDR E. coli strains in
clonally distinct commensal backgrounds. While it is known that horizontally-transferred resistance supplements
uropathogenic strains of E. coli such as ST131, our study demonstrates that the selection of an MDR phenotype in
commensal E. coli strains can result in opportunistic infections in vulnerable patient populations. These strains
provide a reservoir for the onward transfer of resistance alleles into more typically pathogenic strains and
provide opportunities for the coalition of resistance and virulence determinants on plasmids as evidenced by the
IncF replicons characterised in this study.
1. Introduction
E. coli is an important commensal organism and a signiﬁcant pa-
thogen. It is associated with intestinal and extra-intestinal infections
and is a leading cause of urinary tract infections (UTIs) and bacteraemia
leading to sepsis (Pitout, 2010).
Beta-lactam antimicrobials are widely used in both human and an-
imal medicine. Due to their spectrum of activity, pharmacokinetic
characteristics and good safety proﬁle, members of the group are a good
choice in the treatment of UTIs associated with E. coli. However, there is
increasing resistance to these antimicrobials, mediated by the ability of
Enterobacteriaceae such as E. coli, to produce plasmid mediated AmpC
(pAmpC) and extended spectrum beta-lactamase enzymes (ESBLs). This
imparts resistance to most of the Beta-lactam antimicrobials, including
the later generation cephalosporins. In addition, many are also resistant
to other antimicrobial classes rendering them multi-drug resistant
(MDR), signiﬁcantly increasing morbidity and mortality (Harris, 2015).
The prevalence of pAmpC and ESBL resistance is increasing in both
hospital and community acquired infections (Nakai et al., 2016). Less
information is available for companion animals, but studies that have
evaluated this report a resistance epidemiology similar to that observed
in human clinical care (Dierikx et al., 2012; Gibson et al., 2010; Murphy
et al., 2010; Tamang et al., 2012)
Successful dissemination of resistance within MDR E. coli is attri-
butable to the fact that they are mostly located on horizontally trans-
ferable elements (HTEs) such as plasmids and transposable elements.
HTEs are often promiscuous with a diverse bacterial host range, con-
ferring resistance not just within but also between bacterial species,
generating a large potential resistance reservoir (Bortolaia et al., 2011).
It is important to determine the genetic context of resistance alleles to
understand co-inheritance of traits that may drive selection and the
potential of resistances to coalesce in single isolate backgrounds.
As sequencing technologies have advanced, an increasing number of
resistant E. coli strains, have been sequenced. Initially, much of the
sequence comparison relied upon read mapping and short read de novo
assembly. These methods often fail to accurately resolve complete
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chromosomes and other replicons due to multiple repeat regions which
are often present in mobile genetic elements. As a consequence, there is
a relative lack of availability of high quality sequence data relating to
complete bacterial plasmids encoding antibiotic resistance. The advent
of long read sequencing technologies is now leading to increased re-
presentation of these sequences in public databases.
The aim of this study was to characterise MDR E. coli associated
with urinary tract infections in dogs focusing on the use of Illumina
sequencing combined with Paciﬁc Biosciences single molecule real time
(SMRT) sequencing to elucidate the plasmid repertoires that have been
assembled to generate MDR isolates.
2. Materials and methods
2.1. Bacterial strains
All isolates (16 MDR and 14 antibiotic susceptible (AS)) were pre-
viously characterized in terms of bacterial identiﬁcation, phylogenetic
group, plasmid replicon type, MDR phenotype and ST type (Wagner
et al., 2014).
2.2. Illumina sequencing
E. coli isolates were cultured overnight at 37 °C, 170 rpm, in lyso-
geny broth (LB). DNA was extracted using Qiagen DNeasy extraction kit
(Qiagen U.K.). DNA was isolated from 1 ml of bacterial culture, ac-
cording to the manufacturer's speciﬁcations. Following integrity as-
sessment on agarose gels and quantiﬁcation/quality determination by
spectrophotometry (including absorbance 260:280 nm), Nextera XT li-
braries were prepared by Edinburgh Genomics. Paired-end Illumina
sequencing was performed using an Illumina Hi-Seq 2500 sequencer
with read lengths of 100 bp to achieve an average depth of 60×.
2.3. SMRT sequencing
SMRT sequencing was performed using the PacBio platform (Paciﬁc
Biosciences). E. coli were inoculated into 10 ml LB and incubated
overnight at 37 °C, 170 rpm. DNA was extracted using the Qiagen 100/
G extraction kit, according to the manufacturer's instructions. Extracted
DNA was prepared for sequencing using AMPure Beads (Beckman
Coulter), with a target insert size range of 10 kb or greater. DNA was
sheared using a g-TUBE™ (Covaris). Sheared DNA was puriﬁed and
concentrated using AMPure beads. Samples were eluted using PacBio
Elution Buﬀer, and single stranded fragments were removed with
ExoVII DNA. Fragments were then repaired using the PacBio DNA
Damage and Repair Ends buﬀers, as per the protocol. Processed DNA
was further puriﬁed using AMPure beads; then blunt ended sequence
adapters were ligated, and ExoIII and ExoVII restriction enzymes used
to remove any failed ligation products. Successfully ligated sequence
fragments were concentrated using three successive AMPure bead
puriﬁcation steps. Final DNA concentration for all of the samples ex-
ceeded 5 μg. DNA was sequenced on the PacBio RSII sequencing plat-
form.
2.4. Sequence assembly and annotation
Illumina sequence reads were ﬁltered using Sickle (Joshi and Fass,
2011) with a minimum read quality score of 30, and a read length of
50 bp. Reads were re-shuﬄed with shuﬄeSequences fastq.pl script
(Zerbino, 2010). De novo assembly used both paired reads and single-
tons. Illumina sequence reads were assembled with the VelvetOptimiser
script, from Velvet 1.2.08 (Zerbino and Birney, 2008) using a kmer size
range of 47 to 67.
SMRT analysis was used to generate a fastq ﬁle from the PacBio
reads and error-corrected reads were adjusted using PBcR with self-
correction (Koren et al., 2013). Then the longest 20× coverage reads
were assembled with Celera Assembler 8.1 and polished using Quiver
(Chin et al., 2013). Annotated genomes (Do-It-Yourself Annotator
(DIYA) (Stewart et al., 2009)) were imported into Geneious (Biomatters
LTD., Auckland, New Zealand) (Kearse et al., 2012) and duplicated
sequence removed from the 5′ and 3′ ends to generate the circularized
chromosomes/plasmids. Origin of replication was approximated using
Ori-Finder (Luo et al., 2014) and the chromosome reoriented using the
origin as base 1.
2.5. Core genome analysis
To construct core SNPs trees short reads were aligned with BWA
http://www.ncbi.nlm.nih.gov/pubmed/19451168 (Li and Durbin,
2009) to a reference E. coli O157:H7 Sakai strain (RefSeq assembly
accession: GCF\_000008865). Consensus sequence for each alignment
of 5,590,092 bp was produced using the majority rule and then used to
detect and remove recombination regions with Gubbins http://nar.
oxfordjournals.org/content/early/2014/11/20/nar.gku1196.short
(Croucher et al., 2015).
Resulting sequences were used to construct a Maximum Likelihood
(ML) tree with RAxML http://www.ncbi.nlm.nih.gov/pubmed/
24451623 (Stamatakis, 2014) under a GAMMA model of hetero-
geneity with 500 bootstrap replicates.
2.6. Plasmid sequence comparison
CCTViewer (Grant et al., 2012) was used to visualise SMRT se-
quenced plasmids, using 1428 p96 as a reference sequence for the IncI1
plasmids (Accession no CP023370) and 144 p134 (Accession no
CP023363) as the reference for the IncF plasmid (Table 2). Pro-
gressiveMauve (Darling et al., 2010) alignment was performed using
default parameters. ResFinder (Zankari et al., 2012) was used to con-
ﬁrm annotated antimicrobial resistance markers. BlastKOALA
(Kanehisa et al., 2016) was used to identify putative virulence factor
sequences on the plasmid.
2.7. Analysis of plasmid core and pan genomes
Plasmid replicon and clonal complex types were determined using
the pubMLST database (Jolley and Maiden, 2010). Core sequence
homology between the plasmid sequences was detected with GE-
T_HOMOLOGUES (Altschul et al., 1997) using bi-directional best-hits
(BDBHs) and orthoMCL algorithms. Protein clusters were aligned with
Muscle (Edgar, 2004). Amino acid alignments were then translated
back into nucleotide sequences using the PAL2NAL (Suyama et al.,
2006), concatenated and transformed into phyml format with catfas-
ta2phyml/catfasta2phyml.pl script to use for RaXML phylogenetic es-
timation under a GTR model and 100 bootstrap replicates (Stamatakis,
2014). GET_HOMOLOGUES was also used for the pan genome analysis,
using the PARS program from the PHYLIP package (Contreras-Moreira
Table 1
Summary of the E. coli reference strains used in this study.






ABU83972 CP001671 Asymptomatic bacteruria
JJ1886 CP006784 Multi-drug resistant
NA114 CP002797 Multi-drug resistant
uropathogenic
MG1655 NC_000913 Non pathogenic
UMNK88 NC_017641.1 Porcine enterotoxigenic
Sakai 0157:H7 BA000007.2 Human enterohaemorrhagic
APEC O78 CP004009.1 Avian pathogenic




3.1. Comparative analysis of E. coli strains
Core SNP-based phylogenetic analysis of the 30 clinical UTI asso-
ciated isolates (16 MDR and 14 AS) plus 10 reference strains (Table 1)
was carried out, and identiﬁed at least two distinct clusters that mostly
correlates well with the isolates’ MDR status (Fig. 1). Isolates were
ancestrally diverse, however there was a trend for susceptible isolates to
be more closely associated to human UPEC E. coli reference sequences
and MDR isolates clustered together with commensal E. coli reference
sequences. Whole genome sequencing (WGS) analysis of the MDR
strains conﬁrmed previous standard phylotyping results regarding their
diverse commensal backgrounds. Isolates that possess the IncI1/IncF
plasmid genotype were well dispersed throughout the tree. Tree clades
were largely independent with respect to date of isolation.
3.2. Sequencing and plasmid carriage
Plasmid sequences could not be assembled using Illumina short read
sequence data. Therefore, 8 MDR isolates (127, 1223, 1283, 1428, 144,
317, 746 and 1943 (Supplementary Table S1)) were sequenced by
SMRT, these were selected to examine the IncI1 replicon context of the
CMY-2 (AmpC) beta-lactamase. Two sensitive isolates (1190 and 1105,
(Supplementary Table S2)) but carrying an IncI1 replicon were also
sequenced by SMRT. The plasmid combinations present in the MDR
strains are described in Table 2 and depicted in Fig. 2 along with their
contribution to MDR as deﬁned by carriage of speciﬁc resistance alleles.
While 7/8 MDR strains had the anticipated replicons, one isolate
(317) only carried an IncF plasmid, despite PCR and Illumina sequence
data indicating the presence of IncF and IncI1 replicons. It is possible
that the plasmid was lost during the experimental process. One sus-
ceptible isolate, 1105, was PCR positive for the IncI1 genotype, but this
replicon could not be assembled from the SMRT sequence data.
3.3. IncI1 comparative analysis
In the MDR isolates, the IncI1 plasmid sequence sizes ranged from
85 to 96 kb, with between 106 and 113 coding domain sequences;
many of which still had no ascribed function. All but two of the IncI1
plasmids belonged to the same clonal complex (CC-2), determined in
silico, based on the presence and sequence similarity of repI1, ardA,
trbA, sogS, and pilL to previously published IncI1 pMLST proﬁles. As
anticipated, the IncI1 plasmids associated exclusively with the CMY-2
encoded pAmpC beta-lactamase resistance gene; this was located within
a resistance cassette associated with a mobile element (Figs. 2 and 3).
Signiﬁcant periods of time separate isolation of the sequenced
strains; the ﬁrst collected in 2001, the most recent 2011. This makes the
comparison of the IncI1 replicons unique as it provides insight into the
evolution of this resistance-encoding replicon in our local context over
this time period.
BLAST Atlas search using the CCT comparison tool for analysis of
the Incl1 replicons show greater than 90% sequence similarity for most
of the sequences. Multiple collinear blocks, with high synteny and se-
quence similarity and limited large-scale rearrangements were identi-
ﬁed using progressive Mauve (Fig. 3).
IncI1 plasmids were compared against 42 plasmid sequences ob-
tained through GenBank, which were identiﬁed by BLAST as being si-
milar (Supplementary Fig. 1). Pan-genomic analysis detected 305
homologous gene clusters across all sequences. Phylogenetic estima-
tions using homologous cluster presence or absence indicated a close
phylogenetic relationship between all IncI1 plasmids sequenced in this
study including the IncI1 plasmid from the susceptible E. coli isolate in
this study (1190/01 Accession no CP023387). The resistance cassette
conferring CMY-2 mediated pAmpC resistance although not exclusive to
the canine resistance plasmids, was not detected in many other IncI1
sequences available on databases. Ten of the homologous gene clusters:
traL, traM, nikB, traO, traJ, traF, traE, traT, traI, and traX; all relating to
plasmid transfer and replication were core to all the IncI1 plasmid se-
quences (Fig. 4). These were extracted from the pan-genomic analysis
and aligned for maximum likelihood core genome phylogenetic esti-
mation (Supplementary Fig. 1). Despite only weak bootstrap support
overall, the phylogenetic tree is congruent with the predicted in silico
MLST plasmid groups. The IncI1 plasmids included in the analysis were
from diﬀerent Salmonella serovars and E. coli isolated from diﬀerent
animal hosts suggesting that interspecies transmission of the IncI1
plasmids occurs. However, IncI1 sequences associated with bacteria
isolated from humans were largely absent, despite the over re-
presentation of human isolates in databases in general. The majority of
canine sequences form a sub-cluster, with chicken- and porcine-asso-
ciated plasmid sequences being the most similar. Of note, CP009566
and KF434766 are the only two reference IncI1 plasmids associated
with canine clinical infections; isolated in Salmonella enterica serovar
Newport in Arizona in 2015 (Cao et al., 2015) and E. coli in Denmark in
2008 (Hansen et al., 2016) respectively. These were closely related to
the canine E. coli plasmids sequenced in this study even though their
host bacterial strains were obtained from diﬀerent geographical areas
and at diﬀerent times (Supplementary Fig. 1).
Table 2
Plasmid descriptions from isolates following Illumina and SMRT sequencing.
Name* CDS Plasmid MLST Resistance genes Virulence genes
127 p123 140 IncFII: 22 FIA: 6
FIB: 69
aadA5, aph(3′)-1a,
strB, strA, catA1, sul1,
sul2, dfrA17
–
127 p95 105 IncI1:ST2 (CC2) blaCMY-2 –
127 p91 100 nt – –
127 p43 51 nt blaTEM-33, dfrA1 hha, virD, virB
127p39 48 nt – ﬁmD, hha, virD,
virB
1223 p147 150 IncFII:18 – iss, iroN, mchF
1223 p87 97 IncI1:ST23
(CC2)
blaCMY-2 dot
1283 p109 128 IncFII:31 tet(A) TC·FEV.OM3, sit
1283 p92 101 IncI1: ST2
(CC2)
blaCMY-2 dot
1283 p31 41 nt – hha, virD, virB
1283 p7 9 nt strA, strB, sul2,
dfrA14
–
1283 p3 3 nt – –





1428 p96 113 IncI1:ST43 (CC-
)
blaCMY-2 dot
1428 p66 108 IncFII:4 tet(B) –
1428 p48 65 nt – –
144 p134 142 IncFII:2 FIB:1 strA, strB, blaTEM-1b,
sul2, dfrA5
iroC, sit, iuc, mer
144 p92 105 IncI1:ST2 (CC2) blaCMY-2 –
317 p100 105 IncFII:43 – ABC,LPT.P,
TC·OOP, raxB
746 p95 106 IncI1:ST2 (CC2) blaCMY-2 dot
746 p72 116 IncFII:2 § – –
746 p62 102 IncFII:2 § – –
1943 p85 90 IncI1:ST55 (CC-
)
blaCMY-2 dot
1943 p80 86 IncFIB:1 – sit, iuc
1943 p54 59 nt blaTEM-1a, catB3,
dfrA1
hha, virD, virB
*Each plasmid is referred to by the isolate ID followed by the letter p and then a number
which represents the size of the plasmid in KB. nt = non typable, CC = clonal complex,
−= non identiﬁed, § = putative split contig, CDS = coding sequence, ST = sequence
type.
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Fig. 1. Maximum-parsimony tree of E. coli chromosomal sequence alignment. Isolates from this study are listed in red (MDR) or green (AS). Ref-Seq sequences are listed in black. Plasmid
replicon types are designated from left to right by the colour coded squares: FII FIA FIB I1 I2 B/O ×1 R . Phylogroup designations are colour coded in the right hand
column as follows, A = yellow, B1 = blue, B2 = red and D = green. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.).
Fig. 2. Graphical representation of the plasmid carriage of
the E. coli isolates sequenced in this study. Boxes represent
each isolate referred to by their isolate ID. Depicted se-
quences are not to scale. Plasmid sequences are identiﬁed and
distinguished by their sequence length. Plasmid encoded re-
sistance, where detected by BLAST search, is indicated by
colour coding on the plasmids. Plasmid incompatibility type,
where typable, is indicated (either IncF or IncI1).
Chromosomal sequences are not depicted.
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3.4. IncF comparative analysis
The IncF plasmids were more heterogeneous in size (100–147 kb),
the number of coding regions (105–150), and the number and classi-
ﬁcations of various resistance markers. Aminoglycoside, chlor-
amphenicol, potentiated-sulfonamide, and beta-lactam resistance mar-
kers (other than CMY-2) were associated with IncF or smaller untyped
plasmids (Fig. 2).
Despite the greater variety and number of resistance markers shared
amongst some of the IncFII plasmids, ﬁve contained no detectable re-
sistance markers. Virulence genes, mostly associated with iron uptake,
and genes associated with metabolism were detected on many of the
IncF plasmids. In silico replicon typing indicates that many of these
plasmids were of mixed lineage (Table 2). IncF plasmids showed less
sequence similarity when compared by BLAST or by progressiveMauve
sequence analysis. With one exception, all regions of local co-linearity
had little synteny, or support across all the plasmid sequences (Fig. 5).
GenBank BLAST searches identiﬁed 9 sequences similar to the IncFII/
IncFIB plasmids. Pan-genomic maximum parsimony analysis indicated
diverse content (Fig. 6a). No core genes could be identiﬁed for all the
plasmid sequences, although a subset, excluding 1428 p66, 746 p62,
746 p72, and 1943 p80, could be compared using 8 homologous gene
clusters; as with the IncI1 plasmids these genes were mostly associated
with plasmid maintenance and replication, including traA, traL, traE,
traB and traX. The diﬀerent replicon sub-types are depicted in Fig. 6b,
with FII/FIB the most commonly identiﬁed. A singular clade of plas-
mids, exclusively IncFII, showed greater sequence homology than the
remaining plasmid sequences (Fig. 6a & b). Maximum likelihood phy-
logenetic analysis of IncFII, IncFIA, and IncFIB replicon types showed
dispersal of all sequences of diﬀerent replicon types throughout the tree
(Fig. 6b). None of the PCR typed IncFII plasmids sequenced in this study
were members of the same clade and 317 p100 was a signiﬁcant outlier
from the rest of the plasmid sequences.
3.5. Other plasmids
Numerous other extra-chromosomal contigs were detected from
SMRT sequencing. IncI1, IncFII, IncFIA, and IncFIB, were the only
Fig. 3. Core sequence alignment of IncI1 replicon type plasmid sequences, using 1428 p96 as the index sequence. Comparisons were performed using a BLAST Atlas search using the CCT
comparison tool. Both the whole nucleotide sequence (smaller ring) and coding domain sequence speciﬁc (larger ring) BLAST comparisons were carried out. ProgressiveMauve was also
used to compare the plasmids. Local co-linear blocks, detected by progressiveMauve have been annotated onto the BLAST comparisons.
S. Wagner et al. Veterinary Microbiology 211 (2017) 6–14
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detected incompatibility types, yet account for a fraction of plasmid
sequences. The nature of the SMRT sequencing and the analysis means
that these sequences are very unlikely to be part of the main chromo-
some or the plasmids with deﬁned replicon-types. Whilst many of these
do not contain identiﬁable resistance markers, some do. Many of these
sequences do not have established replication and transfer machinery
encoded on them, so their transfer capacity is currently unknown, but
they may represent small replicons that can be co-inherited with other
transferred plasmids or possibly by other methods such as transduction.
4. Discussion
MDR E. coli isolates are relatively rarely isolated from in and out-
patient samples presented for testing at the University of Edinburgh’s
small animal hospital. As previously described (Wagner et al., 2014)
MDR isolates are often associated with animals with complex medical
histories and understanding their emergence in the context of generally
sensitive E. coli isolates (AS) provides an important opportunity to de-
velop our understanding of MDR emergence in a clinical setting.
Combined use of Illumina and SMRT sequencing has allowed de-
tailed examination of individual plasmids and strain background, as
well as an overview of plasmid carriage in the context of individual
isolates.
Phenotypic beta-lactamase resistance is attributed to pAmpC, en-
coded exclusively by the CMY-2 allele on IncI1 replicon plasmids,
forming a notably closely related phylogenetic cluster, with high levels
of homogeneity in the IncI1 plasmid sequence, despite the strains
having been collected over a 10 year period. The CMY-2 allele was the
only identiﬁable resistance gene present on this subset of IncI1 plas-
mids. This has been reported previously in CMY-2 carrying IncI1 plas-
mids isolated from canine, feline and human hosts (Bortolaia et al.,
2014; Sidjabat et al., 2014). The majority of the MDR IncI1 plasmids
share a closest common ancestor, using maximum-likelihood analysis of
the core genome. This is either due to i) limited sequence divergence or
ii) sequence convergence. Given the genetic distance between the sus-
ceptible IncI1 plasmids, the absence of any dominant E. coli clone as-
sociated with the IncI1 plasmids, the lack of any indication of potential
bacterial host range of the plasmids (other than E. coli), and the dis-
cordance of sequence similarity with the chronological sequence of the
E. coli isolates; it is diﬃcult to identify which. The reliability of any
estimation of rates of divergence between the diﬀerent plasmids is
questionable; the identiﬁcation of a similar plasmid backbone in canine
clinical isolates CP009566 and KF434766 from the USA and Scandi-
navia does suggest underlying core genome stability (Bogaerts et al.,
2015; Bortolaia et al., 2014). CMY-2 has also been identiﬁed from
faeces of healthy dogs in a number of geographical locations including
the Netherlands, Mexico, France and Japan, (Baede et al., 2015; Haenni
et al., 2014; Okubo et al., 2014; Rocha-Gracia et al., 2015) and where
determined, the plasmid context is predominantly IncI1. This may in-
dicate that the IncI1-CMY-2 is endemic to the commensal population
especially in the dog. The common use of cephalosporins such as ce-
phalexin in companion animal practice has been implicated in high
prevalence carriage particularly in canine isolates (Haenni et al., 2014).
In comparison to the IncI1 plasmids, the IncF plasmids are more
disparate, in core and pan-genome sequence content. This could be a
consequence of experimental design, as the isolates for this study were
collected based on their pAmpC production, the gene for which is
present on the IncI1 plasmid. However other studies also provide evi-
dence for the relative heterogeneity of the IncF plasmids (Villa et al.,
2010), and relatively few sequences could be identiﬁed in the NCBI
database, sharing nucleotide similarity with the IncF sequences in this
study; with little conservation of resistance markers between one IncF
plasmid and another. Another contrasting feature of the IncF plasmids,
supported by other studies, was their greater compliment of resistance
alleles and putative virulence-associated genes compared to the IncI1
plasmids. As most of the strains containing the IncI1/IncF plasmid
combination speciﬁcally were associated with commensal phylogroups,
we speculate that acquisition of IncF plasmids in combination with
IncI1 drives emergence of normally commensal E. coli strains resulting
in clinical disease in vulnerable patients, especially in the presence of
antibiotic selection. All patients from which MDR isolates were iden-
tiﬁed could without exception fall into this categorisation having sig-
niﬁcant underlying disease, often multiple antibiotic treatments and
some receiving immunosuppressant therapies (Wagner et al., 2014).
The dispersion of resistance genes across diﬀerent plasmids, in many of
the isolates, suggests sequential acquisition perhaps whilst part of the
Fig. 4. Maximum-parsimony analysis using detected presence or absence of homologous
gene clusters from the pan genome of PacBio IncI1 replicon sequences, and comparator
IncI1 sequences obtained from the NCBI nucleotide sequence database. Plasmid se-
quences from this study lie within the red box. Core genome genes (used for maximum-
likelihood analysis) are indicated by *. The CMY-2 resistance cassette, common to the
IncI1 plasmid sequences isolated in this study, is highlighted by the blue box. (For in-
terpretation of the references to colour in this ﬁgure legend, the reader is referred to the
web version of this article.)
Fig. 5. Core sequence alignment of IncFII replicon type plasmid sequences, using 1223
p147 as the index sequence. Comparisons were performed using a BLAST Atlas search
using the CCT comparison tool. Both the whole nucleotide sequence (smaller ring) and
coding domain sequence speciﬁc (larger ring) BLAST comparisons were carried out.
ProgressiveMauve was also used to compare the plasmids. Local co-linear blocks detected
by progressiveMauve have been annotated onto the BLAST comparisons.
S. Wagner et al. Veterinary Microbiology 211 (2017) 6–14
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normal ﬂora of the gastrointestinal tract; as it is unlikely that the
transfer of multiple plasmids would occur as a singular event. Com-
mensal strains have previously been implicated as a signiﬁcant
component of the resistance reservoir (Marshall and Levy, 2011) whilst
other studies have clearly identiﬁed the carriage of CMY-2 in more
typical UPEC strains such as ST 131 (Dashti et al., 2014).
Fig. 6. Maximum parsimony and maximum likelihood analysis for IncFII. a) Maximum parsimony analysis of pan-genomic homologous gene clusters for IncFII replicon sequences.
Similar NCBI nucleotide sequences, with detectably diverse replicon types were included. Isolates sequenced in this study are indicated by the red boxes. b) Maximum-likelihood analysis
of aligned core homologous sequences. Sequences have been annotated with their detected replicon type. FII FIA FIB . (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
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SMRT sequencing identiﬁed strains containing up to 5 plasmids
contributing up to 300KB of additional genetic information. Much of
the function of these coding regions is unknown Sequencing also re-
vealed the presence of small non-typable plasmids of which we were
previously unaware. It is assumed that the acquisition of so much extra-
chromosomal DNA may be energetically costly to the bacterial host,
and many of the plasmids may not be stably maintained in this com-
binatorial manner in these speciﬁc backgrounds without antibiotic se-
lective pressure. The long-term stability of these plasmids within their
host bacterial genomes is currently unknown, but investigation of this
in future work would be of signiﬁcant value.
The MDR E. coli strains characterised in this study were isolated
from clinical cases with signiﬁcant underlying disease, which had re-
ceived often multiple courses of antimicrobial chemotherapy. This re-
presents a model of the genetic and phenotypic adaptation of E. coli to
current clinical practices in both the human and veterinary setting.
Patient vulnerability and antibiotic selective pressures provide an en-
vironment for the emergence of opportunistic MDR resistant E. coli
based on the acquisition of at least two plasmid replicon groups, with
numerous other horizontal DNA molecules also under selection. It will
be of interest to evaluate the long-term stability of extra-chromosomal
DNA in relation to antibiotic selective pressure and individual plasmid
and resistance gene eﬀects. In addition, it would also be of value to
establish the reservoir potential of isolates as a source of resistance. It
could be argued that the commensal background of the isolates requires
a conﬂuence of several factors for disease to occur, but should the
horizontal transfer of plasmids to more pathogenic E. coli occur then the
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